Caricamento...
Interleukin-6: a new therapeutic target in systemic sclerosis?
Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functio...
Salvato in:
| Pubblicato in: | Clin Transl Immunology |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Nature Publishing Group
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4232056/ https://ncbi.nlm.nih.gov/pubmed/25505952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2013.2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|